Most Popular Stories
Featured Jobs
-
Sr. Dir/Dir, Medical Affairs
Azur Pharma, Inc - Philadephia, PA -
Program Executive
Prestige Scientific - Boston, MA -
Looking for Experienced Mechanical Engineer Manager (2344)
The Alpine Group - Washington, DC -
Clinical Research Manager
Prestige Scientific - NW of Boston, MA -
Clinical Data Specialist
Ultimate Solutions, Inc. - Morristown
Webinars
- Oncology Trials: Navigating the Regulatory LandscapeFrom the moment you file an IND application right through clinical development, oncology d
- Moving from Task In-Sourcing to Comprehensive Outsourcing with CROs In this webinar, we will discuss the evolving relationship between pharmaceutical sponsors
Events
- e-Patient Connections 2009
Oct 26-27 — Philadelphia, PA - Project Management Training
August 23-26, 2009 — San Diego, CA - ADAPT Congress: Accelerating Development & Advancing Personalized Therapy
Sept 22-25 — Washington, DC - Centric Health Resources Ultra Orphan Conference 2009
Aug 24-26
Free Newsletter
FierceBiotech is the biotech industry's daily monitor, with a special focus on drug discovery and clinical trials. Keep up to speed with the latest biotechnology trends, breakthroughs and FDA approval news. Join 66,000+ biotechnology and pharma industry professionals who get FierceBiotech via daily email. Sign up today!
Popular Topics
Whitepapers
- Smartsourcing in Eastern Europe.
- Demonstrating MSL Programs' ROI
- The Definitive IP Address Management (IPAM) Intelligence Whitepaper
- eClinical Visions – Clinical Trial Management: Enabling Operational Efficiency
- Outcomes-Based Pricing: Meeting Payer Demands
- Webdevelopment best practices for biotech companies
Should drug and medical device makers be required to report payments made to doctors?
Yes
79%
No
21%
Comments
I think they don't necessarily need to make the payments public, but limit the amounts to a reasonable frame.
Post new comment